Paterson Dan

Verastem, Inc.

President and CEO, Director

Avg. Two Year Performance

(82%) Avg. Purchase Return (35%) Compound

No Sale Track Record

Holdings: 86.49K shares

Last Three Months: 22-Feb-24 -- 21-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

22-May-22 -- 21-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions